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Abstract: The association between fish consumption and new-onset type 2 diabetes is inconsistent 
and differs according to geographical location. We examined the association between the total and 
types of fish consumption and type 2 diabetes using individual participant data from 28 prospective 
cohort studies from the Americas (6), Europe (15), the Western Pacific (6), and the Eastern Mediter-
ranean (1) comprising 956,122 participants and 48,084 cases of incident type 2 diabetes. Incidence 
rate ratios (IRRs) for associations of total fish, shellfish, fatty, lean, fried, freshwater, and saltwater 
fish intake and type 2 diabetes were derived for each study, adjusting for a consistent set of con-
founders and combined across studies using random-effects meta-analysis. We stratified all anal-
yses by sex due to observed interaction (p = 0.002) on the association between fish and type 2 diabe-
tes. In women, for each 100 g/week higher intake the IRRs (95% CIs) of type 2 diabetes were 1.02 
(1.01–1.03, I2 = 61%) for total fish, 1.04 (1.01–1.07, I2 = 46%) for fatty fish, and 1.02 (1.00–1.04, I2 = 33%) 
for lean fish. In men, all associations were null. In women, we observed variation by geographical 
location: IRRs for total fish were 1.03 (1.02–1.04, I2 = 0%) in the Americas and null in other regions. 
In conclusion, we found evidence of a neutral association between total fish intake and type 2 dia-
betes in men, but there was a modest positive association among women with heterogeneity across 
studies, which was partly explained by geographical location and types of fish intake. Future re-
search should investigate the role of cooking methods, accompanying foods and environmental pol-
lutants, but meanwhile, existing dietary regional, national, or international guidelines should con-
tinue to guide fish consumption within overall healthy dietary patterns. 
Keywords: type 2 diabetes; fish; federated meta-analysis; prospective studies 
 
1. Introduction 
The prevalence of type 2 diabetes has been increasing globally, and it is predicted to 
affect an estimated 700 million people by 2045 [1]. The human and monetary cost of dia-
betes is vast. Healthy dietary changes are an important way to reverse the current diabetes 
crisis. Fish consumption has been shown to have cardiometabolic benefits among the gen-
eral population and diabetes patients [2,3]. Benefits such as improved lipid profile and 
reduced inflammation have been attributed to the high content of long-chain n-3 fatty 
acids (LCFAs) [3]. However, the evidence on the benefits of fish intake for the prevention 
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of type 2 diabetes is inconclusive. Systematic reviews and meta-analyses [4–10] have con-
cluded that the association of fish consumption with diabetes risk differs by geographical 
location. Studies from North America reported an increased risk [11,12] of type 2 diabetes 
with fish consumption, while studies from Asia have reported both inverse [13,14] and 
positive [15,16] associations; studies from Europe show either no risk [17,18] or increased 
risk [19], with an overall null summary estimate. Types of fish consumed, cooking meth-
ods and levels of fish contaminants, which might vary by geographical location, are pos-
sible explanations for these heterogeneous findings and whether sex differences may exist 
is unresolved. Methodological issues such as variation in covariate adjustment may also 
contribute.  
Previous systematic reviews lack distinctions between types of fish (for example, 
fatty fish, lean fish, and shellfish), which might underpin the observed differences. Only 
one of the reviews [5] assessed fish types and showed an inverse association for oily fish 
consumption, while other types had null associations with type 2 diabetes. However, the 
results were based on only four studies and were driven by one large study [17]. The evi-
dence on the association between types of fish and type 2 diabetes from individual studies 
remains ambiguous. For example, lean fish intake was positively associated with type 2 
diabetes in the Rotterdam Study [19] but inversely associated in a cohort of Norwegian 
women [20]. Fatty fish intake was found to be weakly inversely associated with type 2 
diabetes in the European Prospective Investigation into Cancer (EPIC)-InterAct study 
[17], but null associations were reported in other studies [19–21]. Similarly, shellfish con-
sumption was inversely associated in the Shanghai Women’s Health Study and the Shang-
hai Men’s Health Study [13] but positively associated with type 2 diabetes in the EPIC-
Norfolk study [21] and a Cohort of Swedish Men [22], while null associations were re-
ported in EPIC-InterAct [21].  
Considering the inconsistency of the previous evidence and the potential limitations 
of a literature-based meta-analysis of published summary results, we used a federated 
meta-analysis of individual data [23] to investigate the association between the total and 
types of fish intake and type 2 diabetes across 28 prospective cohort studies, 11 of which 
did not publish on this association earlier, joined a consortium created as part of the In-
terConnect project [24]. 
2. Materials and Methods 
2.1. Populations 
InterConnect is a European Commission-funded project, which optimises the use of 
existing data by enabling cross-cohort analyses within consortia without pooling of data 
at a central location [24]. For the current research question, 43 studies with information on 
fish intake and incident type 2 diabetes were invited to join the consortium. These studies 
were identified by searching published articles on PubMed containing information on 
type 2 diabetes incidence and dietary fish intake and by reviewing the methodology used 
in each of the identified cohorts. 28 prospective cohort studies were included in the final 
collaborative group. Reasons for non-participation of studies varied, including being un-
able or unwilling to set up a server to allow federated analyses; low priority for the re-
search question; or lacked funding or resources. Of the included studies, 20 studies set up 
a server to allow federated meta-analysis, while two studies performed analyses locally 
and sent results; for the remaining six studies, the data were obtained by the approval of 
data-sharing requests. Characteristics of the participating studies are shown in Supple-
mentary Table S1. All cohorts obtained ethical review board approval at the host institu-
tion and written informed consent from participants. 
Dietary Assessment 
Details of the dietary assessment methods used in the collaborating cohorts are 
shown in Supplementary Table S2. Briefly, 24 cohorts used food frequency questionnaires 
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(FFQ), three cohorts used a dietary history interview, and one cohort used a 24-hour recall. 
The number of fish consumption items available in each cohort is detailed in Supplemen-
tary Table S2. We harmonised the variable for total fish intake (g/d, all cohorts) by sum-
ming all of the available fish items (g/d, all cohorts). The fish items included fatty, lean, 
salted, smoked, and dried fish, seafood other than fish, as well as other types of fish and 
fish products that did not fall into the above categories. For some cohorts, we created total 
fish by summing saltwater and freshwater fish as well as other fish products. The servings 
of fish were transformed into g/d of intake if this was not already available. If no infor-
mation on portion size was available, we considered 120 g to be one serving. The following 
types of fish (g/d) were harmonised: lean fish (fish with low or very low-fat content in 
flesh meat); fatty fish (fish with fat content in flesh meat of >4%); seafood other than fish 
(molluscs and crustaceans); fried fish; salted, smoked, and dried fish; freshwater fish (fish 
predominantly living in a freshwater habitat); saltwater fish (fish predominantly living in 
a saltwater habitat). After checking for linearity by comparing associations across quan-
tiles, we present associations as rate ratios per 100 g/week higher fish intake. 
2.2. Ascertainment of Incident Type 2 Diabetes 
To minimise heterogeneity due to different diagnostic criteria, we defined two har-
monised outcomes: ‘clinically incident type 2 diabetes’ (primary outcome) and ‘incident 
type 2 diabetes’ (secondary outcome). For the primary outcome, a confirmed clinical case 
of type 2 diabetes was considered as fulfilling any one or more of the following criteria: 
(1) ascertained by linkage to a registry or medical record; (2) confirmed anti-diabetic med-
ication usage; (3) self-report of physician diagnosis or anti-diabetic medication, verified 
by any of the following: (a) at least one additional source from 1 or 2 above, (b) biochem-
ical measurement (glucose or HbA1c), (c) a validation study with high concordance. For 
the secondary outcome, which was more inclusive, a case of incident type 2 diabetes was 
confirmed by any of the following criteria: (1) ascertained by linkage to a registry or med-
ical record; (2) confirmed anti-diabetic medication usage; (3) self-report of physician diag-
nosis or antidiabetic medication; or (4) biochemical measurement (glucose or HbA1c). 
2.3. Potential Confounding Factors and Other Covariates 
The following factors were considered as potential confounders: age, sex, education, 
smoking, physical activity, alcohol intake, body mass index (BMI), comorbidities at base-
line (baseline diagnosis of any of the following: myocardial infarction, stroke, cancer, or 
hypertension), energy intake and intake of fibre, red and processed meat, fruit, vegetables, 
and sugary drinks, family history of diabetes, waist circumference, and fish oil supple-
ments. Details of the specific confounding variables used for each cohort are presented in 
Supplementary Table S3. 
2.4. Statistical Analyses 
The analyses were conducted using R (R Core Team, Vienna, Austria) within the 
DataSHIELD federated meta-analysis library [25], permitting analyses to be undertaken 
without the necessity for individual participant data to be transferred and stored at a cen-
tral location with all the advantages of a traditional individual participant data meta-anal-
ysis. For the main analyses, we excluded participants with a diagnosis of any diabetes at 
baseline (prevalent diabetes), those reporting implausible energy intakes (<500 or >3500 
kcal/d for women and <800 or >4200 kcal/d for men) [26] and those with missing values 
for any of the outcomes, exposures, or confounding factors. The incidence rate ratios 
(IRRs) and 95% confidence intervals (CIs) for type 2 diabetes were derived using piece-
wise Poisson regression in each study. The piecewise Poisson regression is available in the 
DataSHIELD library and is very similar to Cox regression. For the 8 countries of the Eu-
ropean Prospective Investigation into Cancer (EPIC)-InterAct case-cohort study, we ap-
plied a correction that is analogous to Prentice weighting (weights of 1 for all cases and 
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 for non-cases) for case-cohort studies in survival anal-
yses when using the piecewise Poisson method [27]. Model 1 included age, sex, education, 
smoking, physical activity, alcohol intake, BMI, and co-morbidities at baseline. Model 2 
also included the following dietary factors: energy intake and intake of fibre, red and pro-
cessed meat, fruit, vegetables, sugary drinks. Some potential confounders (family history 
of diabetes, waist circumference, and fish oil supplement use) were not available for all 
cohorts and were only included in sensitivity analyses. Models were fitted within each 
individual study (or EPIC-InterAct country), and random-effects meta-analysis was used 
to combine effect estimates and to estimate the degree of heterogeneity (I2 statistic) using 
STATA/SE 14.2 (StataCorp, College Station, TX, USA).  
We investigated the effect modification by sex, age, and BMI by including the rele-
vant multiplicative interaction parameter in the models and subsequently combining 
these parameter estimates across studies. If the combined interaction parameter was sta-
tistically significant (p < 0.05), analyses were stratified (for sex and for BMI: BMI < 25 kg/m2 
and BMI ≥ 25 kg/m2). Since the heterogeneity of the association between fish intake and 
type 2 diabetes across different geographical areas was reported in previous meta-anal-
yses [4–10], we further presented the results by the following geographical regions ac-
cording to WHO classification [28]: the Americas, including North and South America; 
Europe; the Eastern Mediterranean; and the Western Pacific, including China, Japan and 
Australia. There were no studies from the African and South-East Asia Regions. We also 
tested whether region or age were significant predictors of the association using meta-
regression. 
3. Results 
Table 1 shows the characteristics of the participants. After exclusions, 956,122 indi-
viduals were included in the analyses. Four cohorts comprised of only women (EPIC-In-
terAct France; Shanghai Women Health Survey; Women Health Initiative; Norwegian 
Women and Cancer Study), and three cohorts comprised of only men (Puerto Rico Heart 
Health Program; Shanghai Men Health Survey; Zutphen Elderly). During follow-up rang-
ing from 4 to 25 years, 48,084 clinically incident cases of type 2 diabetes were recorded for 
the primary endpoint (n = 49,410 when using the secondary outcome of type 2 diabetes 
incidence).  
The estimated total fish intake ranged between 3.7 g/d in the Golestan study to 86.1 
g/d in the Norwegian Women and Cancer study and tended to be higher in far Eastern 
(China, Japan), Nordic (Sweden, Norway), and Mediterranean countries (Spain, Italy) (Ta-
ble 2). Among the different types of fish, lean fish was reported as the most frequently 
consumed fish type in the Americas and Europe. Shellfish was consumed in appreciable 
quantities in China, Japan, Sweden, Norway and Spain. 
There was evidence of interaction between sex and total fish consumption on type 2 
diabetes (p = 0.002) but not for BMI or age, so all the results are presented separately for 
men and women. The results for total fish and clinically incident type 2 diabetes (primary 
outcome) stratified by sex and geographical region are shown in Figures 1 and 2. There 
was no association between fish intake and type 2 diabetes for men (Figure 1) in either 
Model 1 or 2 with low heterogeneity after further adjustments for dietary confounders. In 
women (Figure 2), the most adjusted model showed a positive association between fish 
intake and type 2 diabetes, but there was evidence of heterogeneity between studies (I2 = 
61%). Results were similar when we used the secondary outcome of incident type 2 dia-
betes in both men (Supplementary Figure S1) and women (Supplementary Figure S2). 
We observed some variation by geographical region (Figure 1), although the region 
was not a significant predictor in a meta-regression model (p = 0.09). Fish intake was not 
associated with type 2 diabetes incidence in men in any of the different regions. In women, 
a higher total fish intake was associated with higher type 2 diabetes incidence among 
women in the Americas, and there was a suggestion, albeit non-significant, of a positive 
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association in Europe and Western Pacific regions. Among the types of fish, there was a 
positive association between fatty fish consumption and type 2 diabetes incidence in 
women in the Americas (IRR 1.03, 95%CI: 1.001, 1.064; I2 = 0), but the association was not 
significant in other geographical areas (results not shown).  
We analysed the types of fish intake in relation to the type 2 diabetes incidence (Ta-
bles 3 and 4). Both lean and fatty fish were associated with type 2 diabetes risk among 
women. There was no association between fried fish, salted, dried and smoked fish, salt-
water fish, freshwater fish, or shellfish and type 2 diabetes. Only studies from China and 
Japan contributed to freshwater, saltwater, and salted, dried, and smoked fish; therefore, 
the sample might have been too small to detect an association. 
Table 1. Participant characteristics in the cohorts participating in the InterConnect project on the association between fish 
consumption and type 2 diabetes. 
Cohort (Country) Total (N) 
Women 
(%) 












Mean (SD) BMI 
(kg/m2) 
Americas        
ARIC (US) 9654 56 723 2003 53.7 (5.6) 11.8 (8.8, 23.6) 27.1 (4.9) 
ELSA Brasil (Brazil) 11,351 57 338 957 51.6 (8.9) 3.8 (3.4, 4.0) 26.7 (4.5) 
CARDIA (US) 3920 59 198 198 24.9 (3.5) 25.0 (19.0, 25.0) 24.3 (4.7) 
MESA (US) 4669 54 228 674 61.4 (10.1) 4.0 (4.0, 5.0) 27.9 (5.2) 
PRHHP (Puerto Rico) 6977 0 310 825 54.1 (6.5) 5.0 (5.0, 5.0) 24.9 (3.8) 
WHI (US) 86,296 100 10,233 10,233 63.6 (7.3) 11.8 (7.8, 13.6) 27.1 (5.6) 
Eastern Mediterranean        
Golestan (Iran) 9932 52 532 1148 51.2 (7.8) 4.2 (3.6, 5.6) 26.7 (5.2) 
Europe        
EPIC-InterAct Denmark 3896 44 1970 1970 56.9 (4.4) 10.3 (6.3, 11.6) 27.3 (4.5) 
EPIC-InterAct France 795 100 257 257 56.9 (6.5) 9.2 (7.2, 10.5) 24.5 (4.6) 
EPIC-InterAct Germany 3448 51 1505 1505 52.4 (8.3) 9.5 (4.8, 11.2) 27.6 (4.8) 
EPIC-InterAct Italy 3112 65 1271 1271 51.4 (7.7) 10.8 (6.8, 12.9) 27.3 (4.8) 
EPIC-InterAct the 
Netherlands 
2067 83 741 741 54.1 (10.0) 11.1 (6.4, 12.6) 26.6 (4.5) 
EPIC-InterAct Spain 5584 57 2354 2354 50.3 (7.8) 12.4 (8.9, 13.6) 29.3 (4.5) 
EPIC-InterAct Sweden 3439 55 1574 1574 58.4 (7.4) 12.0 (9.3, 13.6) 26.8 (4.4) 
EPIC-InterAct UK 1858 53 608 608 58.3 (10.5) 10.5 (6.3, 12.2) 26.9 (4.4) 
FMC Health Examination 
(Finland) 
9057 49 481 481 39.0 (15.5) 24.2 (22.5, 25.7) 24.7 (4.1) 
Hoorn (the Netherlands) 1206 54 16 93 60.0 (6.7) 6.4 (6.1, 6.7) 26.1 (3.1) 
NOWAC (Norway) 34,547 100 560 672 49.8 (5.8) 6.0 (6.0, 7.0) 22.4 (3.5) 
COSM and SMC (Sweden) 54,571 46 5339 5432 59.9 (9.0) 18.0 (18.0, 18.0) 25.2 (3.4) 
SUN (Spain) 19,261 60 142 142 37.6 (12.0) 10.1 (5.9, 12.6) 23.5 (3.5) 
Whitehall II (UK) 4554 29 368 632 49.7 (5.9) 16.1 (15.4, 16.5) 25.2 (3.6) 
Zutphen Elderly (the 
Netherlands) 
475 0 11 62 70.9 (4.7) 10.1 (5.3, 10.3) 25.6 (2.8) 
Western Pacific        
AusDiab (Australia) 6017 56 184 363 49.9 (12.3) 11.7 (5.1, 12.2) 27.5 (4.6) 
CKB (China) 482,588 59 9601 9601 51.1 (10.6) 7.2 (6.3, 8.1) 23.5 (3.3) 
JPHC (Japan) 50,054 55 801 801 56.1 (7.6) 5.0 (5.0, 5.0) 23.4 (2.9) 
NHAPC (China) 932 57 178 225 58.3 (6.0) 6.0 (6.0, 6.0) 24.5 (3.3) 
SMHS (China) 61,250 0 2976 2.976 55.3 (9.7) 5.6 (5.0, 6.0) 23.7 (3.0) 
SWHS (China) 74,710 100 4585 4585 52.6 (9.0) 10.2 (9.2, 10.8) 24.0 (3.4) 
ARIC—Atherosclerosis Risk in Communities; ELSA Brasil—Brazilian Longitudinal Study of Adult Health; CARDIA—
Coronary Artery Risk Development in Young Adults Study; MESA—Multi-Ethnic Study of Atherosclerosis; PRHHP—
Puerto Rico Heart Health Program; WHI—Women Health Initiative; FMC—Finnish Mobile Clinic Health Examination 
Survey; NOWAC—Norwegian Women and Cancer; COSM—Cohort of Swedish Men; SMC—Swedish Mammography 
Cohort; SUN—Seguimiento Universidad de Navarra (University of Navarra Follow-up); AusDiab—Australian Diabetes, 
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Obesity and Lifestyle Study; CKB—China Kadoorie Biobank; JPHC—Japan Public Health Center-based; NHAPC—Nu-
trition and Health of Aging Population of China Study; SMHS—Shanghai Men Health Study; SWHS—Shanghai Women 
Health Study. 
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Table 2. The consumption of total and types of fish in the InterConnect Project by region and cohort. 







Americas         
ARIC (US) 26.9 (18.1, 48.5) 1.9 (1.9, 7.7) 7.7 (1.9, 16.4) 1.8 (1.8, 7.6) NA NA NA NA 
ELSA-Brasil (Brazil) 33.0 (18.0, 58.0) NA NA 0.0 (0.0, 3.0) 0.0 (0.0, 12.0) NA NA NA 
CARDIA (US) 34.4 (9.2, 80.5) 0.0 (0.0, 0.0) 19.0 (0.0, 46.0) 3.5 (0.0, 23.0) 0.0 (0.0, 0.0) NA NA NA 
MESA (US) 24.3 (11.7, 47.2) 3.5 (0.0, 9.2) 3.5 (0.0, 9.2) 1.7 (0.0, 4.6) 3.5 (0.0, 9.2) NA NA NA 
PRHHP (Puerto Rico) 0.0 (0.0, 0.0) NA NA 0 (0, 0) NA NA NA NA 
WHI (US) 23.0 (11.8, 40.8) 0.0 (0.0, 5.9) 3.9 (0.0, 9.2) 0.0 (0.0, 5.9) 0.0 (0.0, 3.9) NA NA NA 
Eastern Mediterranean         
Golestan (Iran) 3.7 (0.8, 10.2) 0.0 (0.0, 1.6) 2.2 (0.1, 7.4) NA 0.0 (0.0, 3.1) 0.0 (0.0, 0.0) 3.0 (0.6, 8.9) 0.0 (0.0, 0.0) 
Europe         
EPIC-InterAct Denmark 36.6 (26.0, 57.3) 11.7 (6.9, 18.5) 15.4 (9.9, 23.4) 1.7 (0.9, 4.2) 6.1 (3.0, 12.9) NA NA NA 
EPIC-InterAct France 30.9 (18.6, 47.2) 8.9 (4.0, 16.2) 10.2 (0.0, 20.1) 0.0 (0.0, 4.6) 0.0 (0.0, 0.0) NA NA NA 
EPIC-InterAct Germany 17.2 (9.0, 29.0) 0.0 (0.0, 1.2) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 4.2 (1.6, 6.9) NA NA NA 
EPIC-InterAct Italy 25.3 (14.2, 40.8) 8.1 (3.7, 14.9) 5.1 (1.2, 12.2) 2.8 (0.9, 6.8) 0.0 (0.0, 0.0)  NA NA NA 
EPIC-InterAct the 
Netherlands 
8.4 (3.4, 16.1) 1.4 (0.6, 3.6) 1.5 (0.5, 3.3) 0.7 (0.3, 1.7) 3.0 (1.0, 6.6) NA NA NA 
EPIC-InterAct Spain 56.5 (35.2, 85.5) 11.3 (2.8, 24.4) 25.7 (10.2, 49.1) 3.6 (0.0, 8.6) 0.0 (0.0, 0.0) NA NA NA 
EPIC-InterAct Sweden 36.7 (19.2, 57.6) 2.3 (0.0, 16.3) 0.0 (0.0, 16.6) 1.7 (0.0, 6.1) 2.4 (0.0, 8.3) NA NA NA 
EPIC-InterAct UK 31.6 (18.1, 45.7) 8.1 (0.0, 16.1) 17.9 (8.1, 26.2) 0.0 (0.0, 4.2) 0.0 (0.0, 12) NA NA NA 
FMC (Finland) 19.0 (9.0, 35.0) 6.3 (2.0, 15.0) 7.0 (2.0, 15.0) 0.0 (0.0, 0.0) 4.5 (0.6, 9.3) 4.0 (0.7, 11.0) 5.5 (1.7, 12.8) 7.0 (2.0, 17.0) 
Hoorn (the Netherlands) 12.0 (1.0, 25.0) 1.0 (0.0, 8.0) 3.5 (0.0, 10.0) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) NA NA NA 
NOWAC (Norway) 86.1 (57.2, 123.5) 11.4 (4.8, 21.4) 23.6 (10.9, 40.7) 3.5 (0.0, 3.5) NA NA NA NA 
COSM and SMC (Sweden) 29.0 (20.0, 41.0) 8.0 (6.0, 15.0) 10.0 (8.0, 25.0) 4.0 (3.0, 5.0) 12.3 (4.1, 16.4) NA NA NA 
SUN (Spain) 85.7 (56.9, 128.6) 21.4 (10.0, 64.3) 31.4 (21.4, 74.3) 16.7 (10.0, 20.7) NA 0.0 (0.0, 3.3) NA NA 
Whitehall II (UK) 35.0 (17.5, 52.5) 8.7 (0.0, 17.5) 17.5 (8.7, 26.2) 0.0 (0.0, 8.7) 0.0 (0.0, 8.7) NA NA NA 
Zutphen Elderly (the 
Netherlands) 
13.0 (0.0, 29.0) 0.0 (0.0, 8.0) 8.0 (0.0, 20.0) 0.0 (0.0, 0.0) 0.0 (0.0, 13.0) 0.0 (0.0, 3.0) 13.0 (0.0, 29.0) 0.0 (0.0, 0.0) 
Western Pacific         
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AusDiab (Australia) 25.3 (13.7, 44.0) NA NA NA 3.3 (1.5, 10.3) NA NA NA 
CKB (China) 8.2 (1.2, 32.8) NA NA NA NA NA NA NA 
JPHC (Japan) 79.1 (50.0, 121.2) 27.0 (15.3, 48.9) 8.0 (0.0, 20.0) 10.7 (7.0, 18.3) NA 11.7 (4.4, 25.0) NA 40.1 (24.0, 65.6) 
NHAPC (China) 41.0 (20.7, 69.8) NA NA 5.5 (1.9, 15.9) NA 1.4 (0.5, 3.6) 9.8 (3.3, 21.4) 14.3 (6.6, 28.6) 
SMHS (China) 38.4 (21.0, 66.1) NA NA 11.5 (2.8, 15.0) NA NA 21.5 (6.0, 26.2) 16.5 (3.8, 21.0) 
SWHS (China) 8.9 (1.4, 35.7) NA NA 10.0 (2.3, 12.5) NA NA 20.4 (3.6, 26.2) 17.5 (4.2, 21.0) 
Values are median and interquartile range. ARIC—Atherosclerosis Risk in Communities; ELSA-Brasil—Brazilian Longitudinal Study of Adult Health; CARDIA—
Coronary Artery Risk Development in Young Adults Study; MESA—Multi-Ethnic Study of Atherosclerosis; PRHHP—Puerto Rico Heart Health Program; WHI—
Women Health Initiative; FMC—Finnish Mobile Clinic Health Examination Survey; NOWAC—Norwegian Women and Cancer; COSM—Cohort of Swedish 
Men; SMC—Swedish Mammography Cohort; SUN—Seguimiento Universidad de Navarra (University of Navarra Follow-up); AusDiab—Australian Diabetes, 
Obesity and Lifestyle Study; CKB—China Kadoorie Biobank; JPHC—Japan Public Health Center-based; NHAPC—Nutrition and Health of Aging Population of 
China Study; SMHS—Shanghai Men Health Survey; SWHS—Shanghai Women Health Survey. 
Table 3. Adjusted incidence rate ratios and 95% confidence intervals for the association between the consumption of different types of fish (per 100 g/week) and 
incident type 2 diabetes (primary outcome) in men in the InterConnect project. 
Cohort (Country) Fatty Fish Lean Fish Seafood Fried Fish Salted, Dried Smoked, Fish Saltwater Fish Freshwater Fish 
Americas        
ARIC (US) 1.04 (0.94, 1.16) 1.08 (0.99, 1.18) 1.00 (0.84, 1.17)     
ELSA-Brasil (Brazil)   0.94 (0.74, 1.19) 1.04 (0.92, 1.17)    
CARDIA (US)        
MESA (US) 0.86 (0.66, 1.12) 0.97 (0.80, 1.18) 0.98 (0.90, 1.08) 1.05 (0.85, 1.28)    
PRHHP (Puerto Rico)     1.07 (0.98, 1.16)   
WHI (US)        
Eastern Mediterranean        
Golestan (Iran) 1.01 (0.82, 1.25) 1.03 (0.91, 1.16)  1.08 (0.95, 1.22) 2.54 (0.04, 1.66) 1.02 (0.91, 1.14) 1.75 (0.84, 1.38) 
Europe        
COSM (Sweden) 1.01 (0.98, 1.04) 1.01 (0.99, 1.04) 1.08 (1.01, 1.16) 1.04 (1.00, 1.08)    
EPIC-InterAct Denmark 0.99 (0.91, 1.07) 1.01 (0.91, 1.08) 1.02 (0.84, 1.24) 0.99 (0.90, 1.08)    
EPIC-InterAct France        
EPIC-InterAct Germany    0.93 (0.83, 1.05)    
EPIC-InterAct Italy        
EPIC-InterAct the Netherlands 0.72 (0.41, 1.28) 0.21 (0.08, 0.56) 0.22 (0.05, 1.11) 0.47 (0.29, 0.75)    
EPIC-InterAct Spain 1.00 (0.97, 1.04) 1.01 (0.99, 1.04) 1.03 (0.94, 1.12) 1.01 (0.79, 1.30)    
EPIC-InterAct Sweden 0.98 (0.93, 1.03) 1.10 (1.03, 1.17) 1.33 (1.16, 1.53) 0.95 (0.88, 1.03)    
EPIC-InterAct UK 0.93 (0.81, 1.06) 0.91 (0.80, 1.03) 1.26 (0.84, 1.89) 1.07 (0.81, 1.43)    
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FMC (Finland) 0.95 (0.87, 1.05) 1.03 (0.97, 1.09)  1.02 (0.93, 1.11) 0.94 (0.84, 1.04) 0.95 (0.84, 1.06) 1.01 (0.96, 1.07) 
Hoorn (the Netherlands)        
NOWAC (Norway)        
SUN (Spain) 0.97 (0.88, 1.07) 0.90 (0.93, 1.06) 0.97 (0.82, 1.15)  1.28 (0.50, 3.29)   
Whitehall II (UK) 0.99 (0.89, 1.11) 1.00 (0.89, 1.12) 0.98 (0.78, 1.22) 1.10 (0.94, 1.44)    
Zutphen Elderly (the Netherlands)        
Western Pacific       
AusDiab (Australia)    1.08 (0.90, 1.3)    
CKB (China)        
JPHC (Japan) 0.96 (0.92, 1.01) 0.91 (0.83, 1.00) 0.97 (0.87, 1.07)  1.01 (0.97, 1.06)  0.96 (0.92, 1.00) 
NHAPC (China)   0.86 (0.65, 1.12)  1.05 (0.92, 1.20) 0.95 (0.76, 1.17) 0.94 (0.77, 1.14) 
SMHS (China)   0.97 (0.93, 1.01)   1.00 (0.98, 1.02) 0.99 (0.97, 1.02) 
Overall IRR 0.99 (0.98, 1.01) 1.01 (0.99, 1.04) 1.02 (0.97, 1.08) 1.01 (0.97, 1.06) 1.02 (0.98, 1.06) 1.00 (0.98, 1.01) 0.99 (0.97, 1.01) 
Heterogeneity I2 = 0% I2 = 55% I2 = 56% I2 = 41% I2 = 0% I2 = 0% I2 = 0% 
p < 0.05. ARIC—Atherosclerosis Risk in Communities; ELSA-Brasil—Brazilian Longitudinal Study of Adult Health; CARDIA—Coronary Artery Risk Development 
in Young Adults Study; MESA—Multi-Ethnic Study of Atherosclerosis; PRHHP—Puerto Rico Heart Health Program; WHI—Women Health Initiative; FMC—Finn-
ish Mobile Clinic Health Examination Survey; NOWAC—Norwegian Women and Cancer; COSM—Cohort of Swedish Men; SMC—Swedish Mammography 
Cohort; SUN—Seguimiento Universidad de Navarra (University of Navarra Follow-up); AusDiab—Australian Diabetes, Obesity and Lifestyle Study; CKB—China 
Kadoorie Biobank; JPHC—Japan Public Health Center-based; NHAPC—Nutrition and Health of Aging Population of China Study; SMHS—Shanghai Men Health 
Survey; SWHS—Shanghai Women Health Survey. Adjusted for age, sex (if applicable), education, smoking, physical activity, alcohol intake, BMI, comorbidities at 
baseline, energy intake, intake of fibre, red and processed meat, fruit, vegetables, and sugary drinks. 
Table 4. Adjusted incidence rate ratios and 95% confidence intervals for the association between the consumption of different types of fish (per 100 g/week) and 
incident type 2 diabetes (primary outcome) in women in the InterConnect project. 
Cohort (Country) Fatty Fish Lean Fish Seafood Fried Fish Salted, Dried Smoked, Fish Saltwater Fish Freshwater Fish 
Americas        
ARIC (US) 1.01 (0.91, 1.12) 1.04 (0.98, 1.10) 0.95 (0.77, 1.17)     
ELSA-Brasil (Brazil)   1.09 (0.89, 1.34) 0.99 (0.84, 1.16)    
CARDIA (US)   1.01 (0.92, 1.10)     
MESA (US) 0.98 (0.77, 1.24) 1.06 (0.83, 1.35) 1,07 (0.81, 1.41) 0.83 (0.57, 1.22)    
PRHHP (Puerto Rico)        
WHI (US) 1.03 (1.00, 1.06) 1.00 (0.98, 1.03) 1.03 (0.99, 1.07) 1.14 (1.11, 1.17)    
Eastern Mediterranean        
Golestan (Iran) 0.88 (0.52, 1.47) 1.02 (0.89, 1.17)  1.08 (0.94, 1.25) 1.29 (0.02, 93.6) 0.97 (0.83, 1.13) 1.17 (0.91, 1.52) 
Europe        
EPIC-InterAct Denmark 0.93 (0.84, 1.02) 1.10 (1.01, 1.19) 1.50 (1.15, 1.96) 0.95 (0.84, 1.08)    
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EPIC-InterAct France 1.01 (0.84, 1.22) 1.00 (0.87, 1.14) 0.46 (0.36, 0.58)     
EPIC-InterAct Germany    1.09 (0.91, 1.30)    
EPIC-InterAct Italy   1.14 (0.98, 1.32) 1.46 (0.95, 2.24)    
EPIC-InterAct the Netherlands 1.32 (0.98, 1.78) 0.62 (0.39, 1.00) 1.78 (0.66, 4.81) 0.79 (0.62, 1.00)    
EPIC-InterAct Spain 1.13 (1.08, 1.19) 1.06 (1.03, 1.09) 1.18 (0.99, 1.26) 0.79 (0.53, 1.18)    
EPIC-InterAct Sweden 0.98 (0.92, 1.04) 0.98 (0.90, 1.06) 1.28 (1.09, 1.50) 1.00 (0.88, 1.13)    
EPIC-InterAct UK 1.07 (0.94, 1.22) 0.99 (0.89, 1.10) 1.45 (0.90, 2.32) 1.05 (0.77, 1.44)    
FMC (Finland) 1.06 (0.94, 1.20) 1.09 (1.00, 1.19)  1.09 (0.98, 1.21) 1.09 (0.95, 1.26) 0.99 (0.84, 1.15) 1.11 (1.03, 1.19) 
Hoorn (the Netherlands)        
NOWAC (Norway) 1.04 (0.98, 1.12) 1.00 (0.96, 1.05) 1.09 (0.78, 1.52)     
SMC (Sweden) 1.01 (0.95, 1.07) 1.01 (0.98, 1.04) 1.06 (0.96, 1.18) 1.03 (0.98, 1.08)    
SUN (Spain) 1.12 (1.00, 1.24) 0.94 (0.81, 1.10) 1.06 (0.79, 1.43)  0.41 (0.03, 4.76)   
Whitehall II (UK) 1.03 (0.88, 1.19) 1.03 (0.87, 1.22) 0.97 (0.74, 1.27) 1.06 (0.67, 1.67)    
Zutphen Elderly (the Netherlands)        
Western Pacific       
AusDiab (Australia)    1.11 (0.97, 1.27)    
CKB (China)        
JPHC (Japan) 1.04 (0.99, 1.10)  1.04 (0.93, 1.16) 1.05 (0.94, 1.16)  1.02 (0.96, 1.09)  1.04 (0.99, 1.08) 
NHAPC (China)   1.00 (0.81, 1.24)  0.92 (0.57, 1.49) 0.97 (0.82, 1.15) 0.99 (0.86, 1.14) 
SWHS (China)   1.02 (0.98, 1.05)   1.00 (0.98, 1.02) 1.01 (0.99, 1.03) 
Overall IRR  1.04 (1.01, 1.07) * 1.02 (1.00, 1.04) * 1.04 (0.98, 1.11) 1.04 (0.98, 1.10) 1.03 (0.97, 1.10) 1.00 (0.98, 1.02) 1.04 (1.00, 1.08) 
Heterogeneity I2 = 46% I2 = 33% I2 = 74% I2 = 64% I2 = 0% I2 = 0% I2 = 47% 
p < 0.05. ARIC—Atherosclerosis Risk in Communities; ELSA-Brasil—Brazilian Longitudinal Study of Adult Health; CARDIA—Coronary Artery Risk Development 
in Young Adults Study; MESA—Multi-Ethnic Study of Atherosclerosis; PRHHP—Puerto Rico Heart Health Program; WHI—Women Health Initiative; FMC—Finn-
ish Mobile Clinic Health Examination Survey; NOWAC—Norwegian Women and Cancer; COSM—Cohort of Swedish Men; SMC—Swedish Mammography 
Cohort; SUN—Seguimiento Universidad de Navarra (University of Navarra Follow-up); AusDiab—Australian Diabetes, Obesity and Lifestyle Study; CKB—China 
Kadoorie Biobank; JPHC—Japan Public Health Center-based; NHARC—Nutrition and Health of Aging Population of China Study; SMHS—Shanghai Men Health 
Survey; SWHS—Shanghai Women Health Survey. Adjusted for age, sex (if applicable), and education. 





Figure 1. Incidence rate ratios and 95% confidence intervals for the association between the con-
sumption of total fish (per 100 g/day) and incident type 2 diabetes (primary outcome) in men in 
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the InterConnect project. Model 1 (upper panel) adjusted for age, education, smoking, physical 
activity, alcohol intake, BMI, and comorbidities at baseline. Model 2 (lower panel) was addition-
ally adjusted for dietary factors: energy intake, intake of fibre, red and processed meat, fruit, vege-
tables, and sugary drinks. ARIC—Atherosclerosis Risk in Communities; ELSA Brasil—Brazilian 
Longitudinal Study of Adult Health; CARDIA—Coronary Artery Risk Development in Young 
Adults Study; MESA—Multi-Ethnic Study of Atherosclerosis; PRHHP—Puerto Rico Heart Health 
Program; FMC—Finnish Mobile Clinic Health Examination Survey; COSM—Cohort of Swedish 
Men; SUN—Seguimiento Universidad de Navarra (University of Navarra Follow-up); AusDiab—
Australian Diabetes, Obesity and Lifestyle Study; CKB—China Kadoorie Biobank; JPHC—Japan 
Public Health Center-based; NHAPC—Nutrition and Health of Aging Population of China Study; 
SMHS—Shanghai Men Health Study. 
 




Figure 2. Incidence rate ratios and 95% confidence intervals for the association between the con-
sumption of total fish (per 100 g/day) and incident type 2 diabetes (primary outcome) in women in 
the InterConnect project. Model 1 (upper panel) adjusted for age, education, smoking, physical 
activity, alcohol intake, BMI, comorbidities at baseline. Model 2 (lower panel) was additionally 
adjusted for dietary factors: energy intake, intake of fibre, red and processed meat, fruit, vegeta-
bles, sugary drinks. ARIC—Atherosclerosis Risk in Communities; CARDIA—Coronary Artery 
Risk Development in Young Adults Study; ELSA-Brasil—Brazilian Longitudinal Study of Adult 
Health; MESA—Multi-Ethnic Study of Atherosclerosis; WHI—Women Health Initiative; FMC—
Finnish Mobile Clinic Health Examination Survey; NOWAC—Norwegian Women and Cancer; 
SMC—Swedish Mammography Cohort; SUN—Seguimiento Universidad de Navarra (University 
of Navarra Follow-up); AusDiab—Australian Diabetes, Obesity and Lifestyle Study; CKB—China 
Kadoorie Biobank; JPHC—Japan Public Health Center-based; NHARC—Nutrition and Health of 
Aging Population of China Study; SWHS—Shanghai Women Health Survey. 
To further explore heterogeneity, we stratified results by follow-up time (<10 years, 
≥10 years). There was no difference in results across strata. Among men with <10 years 
follow-up RR was 1.00 (95%CI: 0.99, 1.01), p > 0.05, I2 = 56% and with ≥10 years RR was 
1.01 (95%CI: 0.998, 1.02), I2 = 0%.; among women with <10 years follow-up RR was 1.02 
(95%CI: 1.01, 1.03), I2 = 0% and with ≥10 years RR was 1.02 (95%CI: 1.004, 1.04), I2 = 65%. 
We performed sensitivity analyses to explore how the inclusion of the family history of 
diabetes, waist circumference and fish oil supplements use as covariates affected results 
by conducting analyses only in the subset of studies with any of these variables available 
(Supplementary Table S4). The inclusion of these covariates did not alter the results in the 
subsets of studies with these variables available. Only six studies had information availa-
ble on fish oil supplement use (seven among women), so these results were difficult to 
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evaluate in comparison to the main results. To explore whether any one study was pri-
marily responsible for the heterogeneity, we excluded one at a time each study that dif-
fered substantially from the overall IRR estimate. In men, after excluding EPIC-InterAct 
Netherlands, the I2 value using the most adjusted model dropped from 22% to 0%, with 
an overall null IRR. In women, after exclusion of EPIC-InterAct France, the I2 value de-
creased from 61% to 48%. No other study contributed greatly to heterogeneity. 
4. Discussion 
In this federated meta-analysis of individual-level data of 956,122 adults, including 
48,084 confirmed cases of type 2 diabetes, there was a modest positive association between 
the total, fatty and lean fish intake and type 2 diabetes in women, but not in men. When 
stratified by region, the positive association of total fish and type 2 diabetes remained for 
women in the Americas, where it was also positive for fatty fish consumption. Our study 
provides novel results on the total and types of fish consumption and type 2 diabetes risk 
across world regions, whereas prior evidence was largely limited to total fish intake using 
published literature-based results rather than individual-level data. 
Our findings of a positive association between combined the total fish and shellfish 
intake and the risk of type 2 diabetes among women in the Americas are in accordance 
with previous studies conducted in US cohorts of women [11,12]. The risk of type 2 dia-
betes comparing the highest with the lowest quantile of fish intake was 1.29 (95%CI: 1.05, 
1.57) and 1.32 (95%CI: 0.99, 1.74), respectively, in the Nurses’ Health Study (NHS) and 
NHS II [11]. The same study found a non-significant positive association for men in the 
Health Professionals Follow-Up Study (RR = 1.16; 95%CI: 0.96, 1.41) [11]. An increased 
risk was also found in the Women’s Health Study (RR = 1.49; 95%CI: 1.30, 1.70) [12]. To 
compare with these previous findings, we also analysed the highest (>3 portions a week) 
versus lowest (0–1 portion per week) fish consumption. The IRR for highest versus lowest 
intake for women in the Americas in InterConnect was 1.22 (95%CI: 1.02, 1.46), which is 
comparable to previous studies. Our finding of a positive association between fatty fish 
intake and type 2 diabetes in women in the Americas is novel, as the prior US-based stud-
ies reported only on total fish intake, not types of fish. 
In contrast to previous evidence, we did not find an inverse association between fish 
intake and type 2 diabetes among Asian cohorts. For instance, in a previous analysis by 
the Japan Public Health Center-based (JPHC), total fish intake was inversely associated 
with type 2 diabetes among men but not among women [14]. However, we found no as-
sociation between fish and type 2 diabetes in the same cohort. Similarly, a negative asso-
ciation was reported between total fish and type 2 diabetes in the Shanghai Women Health 
Survey (SWHS) [13], but we did not replicate similar findings in our analyses. The dis-
crepancy between our and previously published results might arise from the adjustment 
for different confounders and from different exposure definitions (e.g., risk per each 100 
g/week increment in our study and highest versus lowest categories in published studies). 
For example, in the SWHS the authors found an inverse association of fish with type 2 
diabetes but did not find a dose-response relationship, which suggests a weak association. 
The longer follow-up time in the current analysis since the publication of these studies a 
decade ago could also contribute to the observed differences. We also harmonised expo-
sures and outcomes, which reduced heterogeneity, at least among Asian and US cohorts, 
and might have contributed to the difference in results. Our analysis included a further 
two Asian studies. In the China Kadoorie Biobank (CKB), we found null associations for 
men (IRR = 1.02; 95%CI: 0.98, 1.04) and women (IRR = 1.00; 95%CI: 0.98, 1.02); however, 
recent findings from CKB showed a modest positive association but only amongst urban 
dwellers [15]. We found a null association in the previously unpublished Nutrition and 
Health of Aging Population of China Study (NHAPC) for both men and women.  
In women in Europe, there was a suggestion that a higher fish intake was associated 
with higher type 2 diabetes incidence, but this was not statistically significant. This result 
is consistent with previous meta-analyses reporting either null or positive associations in 
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Western cohorts [7,8]. We were able to include a larger number of European studies, there-
fore, increasing our power to detect associations compared to previous reviews. We ob-
served moderately high heterogeneity even after adjustment for potential confounders. 
However, after the removal of the only study in which fish was negatively associated with 
type 2 diabetes (EPIC-InterAct France), heterogeneity was decreased among European co-
horts, and the positive association between fish and type 2 diabetes became significant. 
The EPIC-InterAct France cohort, comprised of women teachers, might be healthier than 
the other included studies. In a previous analysis of EPIC-InterAct France, in contrast to 
existing evidence, processed meat consumption was negatively associated with type 2 di-
abetes [29], which might suggest confounding by other unmeasured factors, such as 
healthier dietary patterns or habits. 
The reasons for the small sex difference in IRR that we observed, with a modest pos-
itive association between fish intake and type 2 diabetes in women, but a null association 
in men, are not clear but may include a number of factors such as different dietary pat-
terns, fish cooking methods or by types of fish consumed among men and women as well 
as by residual confounding. We further explored the relationship between types of fish 
and type 2 diabetes. For several types of fish, the heterogeneity of association with type 2 
diabetes across cohorts was lower (I2 ranging from 0–47%) than for total fish (I2 61%), and 
both lean and fatty fish, the most commonly consumed types of fish, were associated with 
a higher risk of type 2 diabetes among women. For seafood and fried fish, the heteroge-
neity across cohorts was higher (I2 74% and 64%, respectively), and there was no signifi-
cant association of these fish types with type 2 diabetes. Another possible explanation for 
the observed sex difference may be differences in the degree of measurement error. Die-
tary under-reporting differs according to sex and age, increasing with older age, and it 
may be more frequent in women than in men [30,31]; therefore, the degree of reporting 
bias in our analyses might be different for men and women. However, foods perceived as 
healthy, such as vegetables and fish, are less likely to be underreported [32]. Reverse cau-
sation might have also been an issue if post-menopausal women at greater risk of cardio-
vascular disease were advised to consume more fish.  
Other not measured factors, such as environmental contaminants, might also have 
contributed to the geographical and sex discrepancy in the risk. Certain fish contaminants, 
including persistent organic pollutants (POP), methyl mercury, polychlorinated biphen-
yls (PCBs), and chlorinated pesticides, which vary by geographical location, have been 
associated with an increased risk of type 2 diabetes [33–37]. Sex differences in the associ-
ation between certain POPs and type 2 diabetes have been reported in several studies, 
with positive associations found among women but not men [38–42]. A possible explana-
tion for sex differences in the association of POPs with type 2 diabetes might be the higher 
body fat composition in women, with consequent higher storage of lipophilic organic pol-
lutants [38]. Although women tend to have lower blood concentrations of lipophilic pol-
lutants, as these substances pass on to the offspring through breastmilk [43], the year in 
which a woman gave birth as well as parity affect this process [44]. Older cohorts of 
women, who are also at higher risk of type 2 diabetes, might accumulate more POPs than 
younger women because they gave birth before POPs’ bans and regulations, such as the 
Montreal Protocol and the Stockholm Convention, were introduced from the 1970s on-
wards [45]. Contaminant measurements were not available in our analysis; therefore, we 
could not test this hypothesis, but future such research is warranted.  
Another potential explanation for the sex difference may include differential status 
and metabolization of omega-3 fatty acids, vitamin D, and selenium, which are important 
nutrient components of fish. Sex-specific effects of vitamin D in the pathogenesis of type 
2 diabetes have been reported. A few studies [46–48] reported an inverse relationship be-
tween 25(OH)D serum levels and fasting insulin, insulin production, and cardiometabolic 
risk only in men. This sex disparity may result from differences in endogenous sex hor-
mones [49]. The active metabolite of vitamin D, 1,25-dihydroxyvitamin D, is involved in 
steroid hormone production, and higher levels are linked to high testosterone in both men 
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and women [50,51]. High testosterone levels have been associated with a higher risk of 
type 2 diabetes among women but decreased the risk among men [49,52]. A similar sex-
ually dimorphic relationship was found for selenium and lipid metabolism, possibly due 
to sex differences in selenium uptake and selenoprotein expression [53]. High serum sele-
nium has been positively correlated with waist circumference, systolic blood pressure, 
triglycerides, fasting glucose, and homeostatic model assessment insulin resistance 
(HOMA-IR) in women, but only with fasting glucose and HOMA-IR in men [54]. Sex dif-
ferences in circulating concentrations of omega-3 fatty acids have also been reported, with 
a suggestion of women’s higher synthesis of long-chain polyunsaturated fatty acids from 
shorter chain n-3 fatty acids [55–57]. A recent systematic review suggested a higher risk 
of type 2 diabetes and insulin resistance measures with omega-3 fatty acids supplementa-
tion at high doses above 4.4 g/d [58]. Therefore, an increase in risk with omega-3 supple-
mentation or possibly also with very high fish intake might be apparent only in women, 
who may already have higher circulating omega-3 fatty acid levels than men. However, 
these explanations are speculative and should be the subject of further investigation in 
studies adequately designed for such research. 
A major strength of our study was the use of individual participant data from 28 
cohort studies, which contributed the largest number to date of incident type 2 diabetes 
cases in an analysis of fish and type 2 diabetes and a large variation in fish intake estimates 
across different geographical locations. The large sample also enabled us to interrogate 
potential interaction by sex, unmasking a sex difference in the association between fish 
intake and type 2 diabetes. We were also able to investigate the association of different 
types of fish with type 2 diabetes, unlike prior research. Unlike previous literature-based 
meta-analyses, we harmonised exposures and outcomes and consistently adjusted for the 
same confounders, which reduced heterogeneity and enhanced comparability across 
studies. Furthermore, consortia-based individual-level meta-analyses reduce the risk of 
publication bias; specifically, we included 11 cohorts that had requisite data but had not 
previously published on this topic. Our federated meta-analysis approach overcame con-
straints of the physical pooling of data due to governance or ethical and resource issues.  
Our study had some limitations. Although we adjusted for a range of potential socio-
demographic, lifestyle, and dietary confounders, we cannot exclude the possibility of re-
sidual confounding due to unmeasured or imprecisely measured factors, which is inher-
ent to observational studies. A further limitation of our analysis is the risk of measurement 
error in estimating fish intake. The majority of the studies used food frequency question-
naires, and only a few used more precise methods such as diet history interviews. Alt-
hough the comparability across studies was greatly enhanced through harmonisation, 
heterogeneity due to different assessments of fish intake and type 2 diabetes, as well as 
other variables, cannot be ruled out. Despite the careful harmonisation of dietary exposure 
variables, the wide difference in dietary habits across geographical areas could not be fully 
captured. It is possible that the positive association between fish and diabetes in women 
in North America might be due to other foods consumed with fish among this population. 
Another limitation was the lack of available data on whether the fish consumed was 
farmed or wild. Our analyses assumed a linear association between exposure and out-
come because of the inability to order a pooled data set, and hence non-linear effects could 
not be examined. Some prior large studies that had previously been published on the as-
sociation between total fish intake and type 2 diabetes incidence were not included in our 
analysis (for instance, NHS, NHS II, and Health Professionals Follow-Up Study). How-
ever, we are reassured that our findings of a positive association between total fish in 
women in US-based North American studies were consistent with the prior publications 
from this region. We attempted to bring together data from diverse geographical locations 
but could not include any cohorts from some world regions such as Africa and South Asia 
because of a lack of prospective studies, highlighting this important gap in global health 
research. 
  




In summary, we found evidence of a neutral association between total fish intake and 
type 2 diabetes in men, but there was a modest positive association among women with 
heterogeneity across studies, which was partly explained by geographical location and 
types of fish intake. Compared to previous meta-analyses that may be subject to publica-
tion bias, our approach facilitated the inclusion of cohorts with data that were previously 
unpublished on this topic and optimised comparability across studies by harmonisation 
and consistent confounder adjustment. The reasons for the observed modest positive as-
sociation between fish intake and type 2 diabetes in women in some Western settings are 
unclear and require further investigation, including an understanding of the accompany-
ing foods and overall dietary patterns within which fish is consumed, as well as cooking 
methods and environmental pollutants. It is important to highlight that until findings 
from further research are available, the existing regional, national, or international guide-
lines on fish consumption should continue to guide fish consumption among individuals 
and populations.  
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